#  Utsa Bhaduri 

Co-Chair, Entrepreneurship Committee 2025-2026

Postdoctoral Fellow in Systems Biology at Precision Vaccines Program (PVP)

Department of Pediatrics at Harvard Medical School and Boston Children’s Hospital

Public Policy Fellow, American Association of Immunologists (AAI)

 

 

 



   ![Utsa Badhuri Co-chair of Entrepreneurship committee](/sites/g/files/omnuum8971/files/styles/hwp_4_5__480x600/public/2026-03/Utsa_Badhuri_headshot.png?itok=vXWweTD6) 

 



 





 

Dr. Utsa Bhaduri, PhD, serves as Co-Chair of the Entrepreneurship Committee at HMPA. He leads entrepreneurship initiatives in collaboration with the Harvard Medical School Office for Postdoctoral Fellows (OPF) to promote innovation, venture capital and consulting exposure, startup engagement, and translational research opportunities for postdocs, while strengthening connections with the broader Boston-area biotech community. He coordinates workshops, seminars, and industry engagements for Harvard/HMS postdocs with founders, CEOs, investors, management consultants, and leaders across life sciences, biotech, medtech, healthcare, and medicine.

Dr. Bhaduri received his PhD in Molecular Biomedicine from the University of Trieste, Italy, and was awarded Marie Curie Fellowship (MSCA-ITN) from the European Commission. He is currently a Postdoctoral Research Fellow at Harvard Medical School, Department of Pediatrics, and the Precision Vaccines Program (PVP) at Boston Children’s Hospital, specializing in systems immunology and immunometabolism for precision vaccine development. He is actively involved in multinational consortia, including the Expanded Program for Immunization Consortium–Human Immunology Project Consortium (EPIC-HIPC), the International Network of Special Immunization Services (INSIS), and the Immune Development in Early Life (IDEaL) program. His research integrates experimental and computational systems biology to uncover temporal immunometabolic signatures, leveraging large-scale omics, high-dimensional single-cell, immunophenotyping, and clinical data from diverse global cohorts using AI/ML approaches. At PVP, his research is supported by global organizations, including CEPI (Coalition for Epidemic Preparedness Innovations). Dr. Bhaduri has been named a 2026–27 Public Policy Fellow by the American Association of Immunologists (AAI). He is deeply passionate about basic science, transformative innovation, and academic entrepreneurship at the intersection of precision medicine, artificial intelligence, and immunology.